{"id":"https://openalex.org/W2015685474","doi":"https://doi.org/10.1111/j.1365-2133.1993.tb03532.x","title":"Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993","display_name":"Cyclosporin A in severe, therapy-resistant atopic dermatitis: report of an international workshop, April 1993","publication_year":1993,"publication_date":"1993-08-01","ids":{"openalex":"https://openalex.org/W2015685474","doi":"https://doi.org/10.1111/j.1365-2133.1993.tb03532.x","mag":"2015685474","pmid":"https://pubmed.ncbi.nlm.nih.gov/7654593"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2133.1993.tb03532.x","doi":"https://doi.org/10.1111/j.1365-2133.1993.tb03532.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.1993.tb03532.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109176000","display_name":"Richard D R Camp","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I153648349","display_name":"University of Leicester","ror":"https://ror.org/04h699437","country_code":"GB","type":"education","lineage":["https://openalex.org/I153648349"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"R.D.R. CAMP","raw_affiliation_strings":["Section of Dermatology, University of Leicester, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Dermatology, University of Leicester, U.K","institution_ids":["https://openalex.org/I153648349"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075632567","display_name":"Sakari Reitamo","orcid":"https://orcid.org/0000-0002-7819-9844","observed_orcids":["https://orcid.org/0000-0002-7819-9844"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"raw_author_name":"S. REITAMO","raw_affiliation_strings":["Department of Dermatology, Helsinki University Central Hospital, Helsinki, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Helsinki University Central Hospital, Helsinki, Finland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111482279","display_name":"Peter Simon Friedmann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802775644","display_name":"Royal Liverpool University Hospital","ror":"https://ror.org/01ycr6b80","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802729160","https://openalex.org/I2802775644"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"P.S. FRIEDMANN","raw_affiliation_strings":["Department of Dermatology, Royal Liverpool University Hospital, Liverpool, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Royal Liverpool University Hospital, Liverpool, U.K","institution_ids":["https://openalex.org/I2802775644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076177681","display_name":"VINCENT C. HO","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I141945490","display_name":"University of British Columbia","ror":"https://ror.org/03rmrcq20","country_code":"CA","type":"education","lineage":["https://openalex.org/I141945490"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"V. HO","raw_affiliation_strings":["Division of Dermatology, University of British Columbia, Vancouver, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Dermatology, University of British Columbia, Vancouver, Canada","institution_ids":["https://openalex.org/I141945490"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5064861085","display_name":"Freerk Heule","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267036","display_name":"Academisch Ziekenhuis Rotterdam","ror":"https://ror.org/00xtwy257","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2801952686","https://openalex.org/I4405267036"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"F. HEULE","raw_affiliation_strings":["Department of Dermatology, University Hospital Dijkzigt, Rotterdam, The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, University Hospital Dijkzigt, Rotterdam, The Netherlands","institution_ids":["https://openalex.org/I4405267036"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5109176000"],"corresponding_institution_ids":["https://openalex.org/I153648349"],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":5.3864,"has_fulltext":false,"cited_by_count":52,"citation_normalized_percentile":{"value":0.95968791,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"129","issue":"2","first_page":"217","last_page":"220"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9350000023841858},{"id":"https://openalex.org/keywords/severe-atopic-dermatitis","display_name":"severe atopic dermatitis","score":0.8050000071525574},{"id":"https://openalex.org/keywords/oral-immunosuppressive-therapy","display_name":"oral immunosuppressive therapy","score":0.7900000214576721},{"id":"https://openalex.org/keywords/short-term-treatment-efficacy","display_name":"short-term treatment efficacy","score":0.6690000295639038},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6859999895095825},{"id":"https://openalex.org/keywords/chronic-toxicity","display_name":"chronic toxicity","score":0.640999972820282},{"id":"https://openalex.org/keywords/patient-monitoring","display_name":"patient monitoring","score":0.5590000152587891}],"concepts":[{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.9427889585494995},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8800246715545654},{"id":"https://openalex.org/C2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","level":2,"score":0.7374988794326782},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6693519353866577},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5001132488250732},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.44255414605140686},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13289165496826172},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.12637126445770264},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011565","descriptor_name":"Psoriasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012449","descriptor_name":"Safety","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017408","descriptor_name":"Guidelines as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018579","descriptor_name":"Patient Selection","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2133.1993.tb03532.x","doi":"https://doi.org/10.1111/j.1365-2133.1993.tb03532.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.1993.tb03532.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:7654593","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7654593","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Conference Proceedings"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W156305783","https://openalex.org/W1499298437","https://openalex.org/W1966946167","https://openalex.org/W2003142784","https://openalex.org/W2051612462","https://openalex.org/W2059096434","https://openalex.org/W2062524549","https://openalex.org/W2092571798","https://openalex.org/W2115710949","https://openalex.org/W2122022191","https://openalex.org/W2338260086","https://openalex.org/W2396839229","https://openalex.org/W2417371023"],"related_works":["https://openalex.org/W2066752294","https://openalex.org/W2094349679","https://openalex.org/W2319555040","https://openalex.org/W1532269352","https://openalex.org/W4244168492","https://openalex.org/W1987327541","https://openalex.org/W1497687130","https://openalex.org/W2062524549","https://openalex.org/W2329872581","https://openalex.org/W2000097501"],"abstract_inverted_index":{"Data":[0],"on":[1],"the":[2,146,159,167,175],"use":[3,160,176],"of":[4,21,41,64,133,151,161,169,177],"oral":[5],"cyclosporin":[6,162],"A":[7],"(CyA;":[8],"Sandimmun)":[9],"therapy":[10],"for":[11,57],"severe":[12,170],"adult":[13,24],"atopic":[14,69,84,117],"dermatitis":[15,70,85],"have":[16,27],"accumulated":[17],"since":[18],"1987.":[19],"Details":[20],"over":[22],"200":[23],"patients":[25,43,86,94,136],"who":[26,155],"received":[28],"short-term":[29,65],"CyA":[30,54,66,112,140],"were":[31],"presented":[32],"at":[33],"an":[34],"international":[35],"workshop":[36],"in":[37,46,52,68,97,116,158,166,174],"April":[38],"1993.":[39],"Eighty-six":[40],"these":[42],"had":[44],"participated":[45],"three":[47],"randomized,":[48],"double-blind,":[49],"placebo-controlled":[50],"studies":[51],"which":[53],"was":[55],"given":[56],"6-8":[58],"weeks.":[59],"The":[60],"efficacy":[61],"and":[62,101,148,164,173],"safety":[63],"treatment":[67],"is":[71,121,128,137,156],"established,":[72],"provided":[73],"that":[74,83,110],"appropriate":[75],"guidelines":[76],"are":[77,87,104],"observed.":[78],"Evidence":[79],"to":[80,91],"date":[81],"suggests":[82],"no":[88],"more":[89,99],"prone":[90],"toxicity":[92],"than":[93],"with":[95],"psoriasis,":[96],"whom":[98],"detailed":[100],"longer-term":[102],"data":[103,107],"available.":[105],"Early":[106],"also":[108],"suggest":[109],"long-term":[111,124],"may":[113],"be":[114,143],"effective":[115],"dermatitis,":[118],"but":[119],"there":[120],"concern":[122],"regarding":[123],"safety,":[125],"as":[126],"experience":[127],"still":[129],"limited.":[130],"Careful":[131],"monitoring":[132],"all":[134],"CyA-treated":[135],"therefore":[138],"mandatory.":[139],"should":[141],"only":[142],"used":[144],"under":[145],"direct":[147],"regular":[149],"supervision":[150],"a":[152],"hospital-based":[153],"dermatologist":[154],"knowledgeable":[157],"A,":[163],"experienced":[165],"management":[168],"skin":[171],"disease":[172],"potentially":[178],"toxic":[179],"drugs.":[180]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}